Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction

被引：0
|
作者：
Agata Buonacera
Benedetta Stancanelli
Lorenzo Malatino
机构：
[1] University of Catania,Academic Unit of Internal Medicine and Hypertension Centre, Department of Clinical and Experimental Medicine
[2] c/o Cannizzaro Hospital,undefined
来源：
High Blood Pressure & Cardiovascular Prevention | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 332
页数：1
相关论文
共 50 条
  • [1] Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Buonacera, Agata
    Stancanelli, Benedetta
    Malatino, Lorenzo
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (04) : 331 - 332
  • [2] Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pericas, Pere
    Mas-Llado, Caterina
    Ramis-Barcelo, Maria Francisca
    Valadron, Isabel
    Noris Mora, Marta
    Pasamar Marquez, Lucia
    Gonzalez Colino, Rosa
    Forteza Alberti, Jose Francisco
    Peral Disdier, Vicente
    Rossello, Xavier
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 167 - 175
  • [3] Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pere Pericas
    Caterina Mas-Lladó
    Maria Francisca Ramis-Barceló
    Isabel Valadrón
    Marta Noris Mora
    Lucía Pasamar Márquez
    Rosa González Colino
    José Francisco Forteza Albertí
    Vicente Peral Disdier
    Xavier Rossello
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 167 - 175
  • [4] DIASTOLIC FUNCTION IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED BY SACUBITRIL/VALSARTAN
    Lamaida, N.
    Cerciello, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [5] TOLERABILITY OF SACUBITRIL-VALSARTAN IN PATIENTS WITH CANCER AND HEART FAILURE WITH REDUCED EJECTION FRACTION
    Yarrabothula, Akshitha R.
    Alsheikh-Kassim, Mohammad
    Amatullah, Atia
    Fossas, Jose
    Salman, Justin
    Seal, Zachary
    Lin, Heather
    Irizarry-Caro
    Wanna, Charles
    Miller, Chase
    Fatakdawala, Mariya
    Palaskas, Nicolas L.
    Deswal, Anita
    Koutroumpakis, Efstratios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2325 - 2325
  • [6] Clinical benefit of sacubitril-valsartan in patients with heart failure with reduced ejection fraction
    Spinoni, Enrico Guido
    Lio, Veronica
    Degiovanni, Anna
    Erbetta, Riccardo
    Marino, Paolo
    Patti, Giuseppe
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N101 - N101
  • [7] Sacubitril-Valsartan Treatment Improves Vascular Function And Functional Capacity In Heart Failure With Reduced Ejection Fraction
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Park, Soung Hun
    Jarrett, Catherine L.
    Stehlik, Josef
    Smith, Adam
    Richardson, Russell S.
    Wray, D. Walter
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2020, 52 (07) : 236 - 236
  • [8] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 681 - +
  • [9] Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
    Passino, Claudio
    Sciarrone, Paolo
    Vergaro, Giuseppe
    Borrelli, Chiara
    Spiesshoefer, Jens
    Gentile, Francesco
    Emdin, Michele
    Giannoni, Alberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 112 - 119
  • [10] Echocardiographic changes in elderly patients with heart failure with reduced ejection fraction after sacubitril-valsartan treatment
    Gu, Wei
    Xu, Chuangye
    Li, Zhao
    Li, Zhi-Zhong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2021, 11 (05) : 1093 - 1100
12345